Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts
Matteo Bassetti,
Antonio Vena,
Marco Meroi,
Celia Cardozo,
Guillermo Cuervo,
Daniele Roberto Giacobbe,
Miguel Salavert,
Paloma Merino,
Francesca Gioia,
Mario Fernández-Ruiz,
Luis Eduardo López-Cortés,
Benito Almirante,
Laura Escolà-Vergé,
Miguel Montejo,
Manuela Aguilar-Guisado,
Pedro Puerta-Alcalde,
Mariona Tasias,
Alba Ruiz-Gaitán,
Fernando González,
Mireia Puig-Asensio,
Francesc Marco,
Javier Pemán,
Jesus Fortún,
Jose Maria Aguado,
Alejandro Soriano,
Jordi Carratalá,
Carolina Garcia-Vidal,
Maricela Valerio,
Assunta Sartor,
Emilio Bouza,
Patricia Muñoz
Affiliations
Matteo Bassetti
Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata
Antonio Vena
Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata
Marco Meroi
Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata
Celia Cardozo
Hospital Clínic, IDIBAPS (Institut d’Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona
Guillermo Cuervo
Hospital Universitari de Bellvitge, IDIBELL (Institut D’Investigació Biomèdica de Bellvitge), Universitat de Barcelona
Daniele Roberto Giacobbe
Department of Health Sciences, University of Genoa
Miguel Salavert
Hospital Universitari I Politecnic “La Fe”
Paloma Merino
Hospital Universitario Clínico “San Carlos”
Francesca Gioia
Hospital Universitario “Ramón y Cajal”
Mario Fernández-Ruiz
Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (i+12), Universidad Complutense de Madrid
Luis Eduardo López-Cortés
Unidad Clínica de Enfermedades Infecciosas y Microbiología Clínica, Hospital Universitario Virgen Macarena/Instituto de Biomedicina de Sevilla (IBiS)/Universidad de Sevilla/Centro Superior de Investigaciones Científicas
Benito Almirante
Hospital Universitari Vall d’Hebron, VHIR (Vall d’Hebron Institut de Recerca), Universitat Autònoma de Barcelona
Laura Escolà-Vergé
Hospital Universitari Vall d’Hebron, VHIR (Vall d’Hebron Institut de Recerca), Universitat Autònoma de Barcelona
Miguel Montejo
Hospital Universitario “Cruces”
Manuela Aguilar-Guisado
Hospital Universitario “Virgen del Rocío”
Pedro Puerta-Alcalde
Hospital Clínic, IDIBAPS (Institut d’Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona
Mariona Tasias
Hospital Universitari I Politecnic “La Fe”
Alba Ruiz-Gaitán
Hospital Universitari I Politecnic “La Fe”
Fernando González
Hospital Universitario Clínico “San Carlos”
Mireia Puig-Asensio
Hospital Universitari Vall d’Hebron, VHIR (Vall d’Hebron Institut de Recerca), Universitat Autònoma de Barcelona
Francesc Marco
Hospital Clínic, IDIBAPS (Institut d’Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona
Javier Pemán
Hospital Universitari I Politecnic “La Fe”
Jesus Fortún
Hospital Universitario “Ramón y Cajal”
Jose Maria Aguado
Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (i+12), Universidad Complutense de Madrid
Alejandro Soriano
Hospital Clínic, IDIBAPS (Institut d’Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona
Jordi Carratalá
Hospital Universitari de Bellvitge, IDIBELL (Institut D’Investigació Biomèdica de Bellvitge), Universitat de Barcelona
Carolina Garcia-Vidal
Hospital Clínic, IDIBAPS (Institut d’Investigacions biomèdiques Agust Pi i Sunyer), Universitat de Barcelona
Maricela Valerio
Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón
Assunta Sartor
Microbiology Unit, Azienda Sanitaria Universitaria Integrata Santa Maria della Misericordia
Emilio Bouza
Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón
Patricia Muñoz
Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón
Abstract Background Almost one third of the patients with candidemia develop septic shock. The understanding why some patients do and others do not develop septic shock is very limited. The objective of this study was to identify variables associated with septic shock development in a large population of patients with candidemia. Methods A post hoc analysis was performed on two prospective, multicenter cohort of patients with candidemia from 12 hospitals in Spain and Italy. All episodes occurring from September 2016 to February 2018 were analyzed to assess variables associated with septic shock development defined according to The Third International Consensus Definition for Sepsis and Septic Shock (Sepsis-3). Results Of 317 candidemic patients, 99 (31.2%) presented septic shock attributable to candidemia. Multivariate logistic regression analysis identifies the following factors associated with septic shock development: age > 50 years (OR 2.57, 95% CI 1.03–6.41, p = 0.04), abdominal source of the infection (OR 2.18, 95% CI 1.04–4.55, p = 0.04), and admission to a general ward at the time of candidemia onset (OR 0.21, 95% CI, 0.12–0.44, p = 0.001). Septic shock development was independently associated with a greater risk of 30-day mortality (OR 2.14, 95% CI 1.08–4.24, p = 0.02). Conclusions Age and abdominal source of the infection are the most important factors significantly associated with the development of septic shock in patients with candidemia. Our findings suggest that host factors and source of the infection may be more important for development of septic shock than intrinsic virulence factors of organisms.